Cargando…

External validation of predictive scores for diabetes remission after metabolic surgery

PURPOSE: Bariatric surgery has proven to be the most efficient treatment for obesity and type 2 diabetes mellitus (T2DM). Despite detailed qualification, desirable outcome after an intervention is not achieved by every patient. Various risk prediction models of diabetes remission after metabolic sur...

Descripción completa

Detalles Bibliográficos
Autores principales: Karpińska, Izabela A., Choma, Joanna, Wysocki, Michał, Dudek, Alicja, Małczak, Piotr, Szopa, Magdalena, Pędziwiatr, Michał, Major, Piotr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847237/
https://www.ncbi.nlm.nih.gov/pubmed/34255166
http://dx.doi.org/10.1007/s00423-021-02260-3
_version_ 1784652009609101312
author Karpińska, Izabela A.
Choma, Joanna
Wysocki, Michał
Dudek, Alicja
Małczak, Piotr
Szopa, Magdalena
Pędziwiatr, Michał
Major, Piotr
author_facet Karpińska, Izabela A.
Choma, Joanna
Wysocki, Michał
Dudek, Alicja
Małczak, Piotr
Szopa, Magdalena
Pędziwiatr, Michał
Major, Piotr
author_sort Karpińska, Izabela A.
collection PubMed
description PURPOSE: Bariatric surgery has proven to be the most efficient treatment for obesity and type 2 diabetes mellitus (T2DM). Despite detailed qualification, desirable outcome after an intervention is not achieved by every patient. Various risk prediction models of diabetes remission after metabolic surgery have been established to facilitate the decision-making process. The purpose of the study is to validate the performance of available risk prediction scores for diabetes remission a year after surgical treatment and to determine the optimal model. METHODS: A retrospective analysis comprised 252 patients who underwent Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy (SG) between 2009 and 2017 and completed 1-year follow-up. The literature review revealed 5 models, which were subsequently explored in our study. Each score relationship with diabetes remission was assessed using logistic regression. Discrimination was evaluated by area under the receiver operating characteristic (AUROC) curve, whereas calibration by the Hosmer–Lemeshow test and predicted versus observed remission ratio. RESULTS: One year after surgery, 68.7% partial and 21.8% complete diabetes remission and 53.4% excessive weight loss were observed. DiaBetter demonstrated the best predictive performance (AUROC 0.81; 95% confidence interval (CI) 0.71–0.90; p-value > 0.05 in the Hosmer–Lemeshow test; predicted-to-observed ratio 1.09). The majority of models showed acceptable discrimination power. In calibration, only the DiaBetter score did not lose goodness-of-fit in all analyzed groups. CONCLUSION: The DiaBetter score seems to be the most appropriate tool to predict diabetes remission after metabolic surgery since it presents adequate accuracy and is convenient to use in clinical practice. There are no accurate models to predict T2DM remission in a patient with advanced diabetes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00423-021-02260-3.
format Online
Article
Text
id pubmed-8847237
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-88472372022-02-23 External validation of predictive scores for diabetes remission after metabolic surgery Karpińska, Izabela A. Choma, Joanna Wysocki, Michał Dudek, Alicja Małczak, Piotr Szopa, Magdalena Pędziwiatr, Michał Major, Piotr Langenbecks Arch Surg Original Article PURPOSE: Bariatric surgery has proven to be the most efficient treatment for obesity and type 2 diabetes mellitus (T2DM). Despite detailed qualification, desirable outcome after an intervention is not achieved by every patient. Various risk prediction models of diabetes remission after metabolic surgery have been established to facilitate the decision-making process. The purpose of the study is to validate the performance of available risk prediction scores for diabetes remission a year after surgical treatment and to determine the optimal model. METHODS: A retrospective analysis comprised 252 patients who underwent Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy (SG) between 2009 and 2017 and completed 1-year follow-up. The literature review revealed 5 models, which were subsequently explored in our study. Each score relationship with diabetes remission was assessed using logistic regression. Discrimination was evaluated by area under the receiver operating characteristic (AUROC) curve, whereas calibration by the Hosmer–Lemeshow test and predicted versus observed remission ratio. RESULTS: One year after surgery, 68.7% partial and 21.8% complete diabetes remission and 53.4% excessive weight loss were observed. DiaBetter demonstrated the best predictive performance (AUROC 0.81; 95% confidence interval (CI) 0.71–0.90; p-value > 0.05 in the Hosmer–Lemeshow test; predicted-to-observed ratio 1.09). The majority of models showed acceptable discrimination power. In calibration, only the DiaBetter score did not lose goodness-of-fit in all analyzed groups. CONCLUSION: The DiaBetter score seems to be the most appropriate tool to predict diabetes remission after metabolic surgery since it presents adequate accuracy and is convenient to use in clinical practice. There are no accurate models to predict T2DM remission in a patient with advanced diabetes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00423-021-02260-3. Springer Berlin Heidelberg 2021-07-13 2022 /pmc/articles/PMC8847237/ /pubmed/34255166 http://dx.doi.org/10.1007/s00423-021-02260-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Karpińska, Izabela A.
Choma, Joanna
Wysocki, Michał
Dudek, Alicja
Małczak, Piotr
Szopa, Magdalena
Pędziwiatr, Michał
Major, Piotr
External validation of predictive scores for diabetes remission after metabolic surgery
title External validation of predictive scores for diabetes remission after metabolic surgery
title_full External validation of predictive scores for diabetes remission after metabolic surgery
title_fullStr External validation of predictive scores for diabetes remission after metabolic surgery
title_full_unstemmed External validation of predictive scores for diabetes remission after metabolic surgery
title_short External validation of predictive scores for diabetes remission after metabolic surgery
title_sort external validation of predictive scores for diabetes remission after metabolic surgery
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847237/
https://www.ncbi.nlm.nih.gov/pubmed/34255166
http://dx.doi.org/10.1007/s00423-021-02260-3
work_keys_str_mv AT karpinskaizabelaa externalvalidationofpredictivescoresfordiabetesremissionaftermetabolicsurgery
AT chomajoanna externalvalidationofpredictivescoresfordiabetesremissionaftermetabolicsurgery
AT wysockimichał externalvalidationofpredictivescoresfordiabetesremissionaftermetabolicsurgery
AT dudekalicja externalvalidationofpredictivescoresfordiabetesremissionaftermetabolicsurgery
AT małczakpiotr externalvalidationofpredictivescoresfordiabetesremissionaftermetabolicsurgery
AT szopamagdalena externalvalidationofpredictivescoresfordiabetesremissionaftermetabolicsurgery
AT pedziwiatrmichał externalvalidationofpredictivescoresfordiabetesremissionaftermetabolicsurgery
AT majorpiotr externalvalidationofpredictivescoresfordiabetesremissionaftermetabolicsurgery